What is Hca Healthcare Inc's earnings per share (EPS)?

Hca Healthcare Inc (HCA) reported diluted earnings per share of $28.33 for fiscal year 2025. This represents a 28.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Hca Healthcare Inc Financials

HCA

FY2025 annual

Revenue $75.6B +7.1% YoY

Net Income $6.8B +17.8% YoY

EPS (Diluted) $28.33 +28.8% YoY

Free Cash Flow $7.7B +36.4% YoY

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

Hca Healthcare Inc (HCA) reported $75.6B in revenue for fiscal year 2025, up 7.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HCA FY2025 2026-04-29

HCA’s cash-generating healthcare model is funding aggressive buybacks faster than it rebuilds liquidity or balance-sheet equity.

By FY2025, operating cash flow climbed to $12.6B while capex held near $4.9B, pushing free cash flow to $7.7B; that widening gap funded $10.1B of buybacks even as cash fell to $1.0B and the current ratio slipped to 1.0x. The operating engine is therefore producing more spendable cash, but management is channeling it toward capital return rather than building a thicker cash buffer or repairing book equity.

From FY2023 to FY2025, revenue rose 16.4% but operating cash flow rose 34.0%, so the earnings recovery is showing up in cash as well as profit. In FY2025, free-cash-flow margin of 10.2% exceeded net margin of 9.0%, which implies reported earnings were backed by cash and not heavily absorbed by working capital.

Across FY2021-FY2025, net income was down 2.5% while diluted EPS was up 33.9%. The gap is largely a share-count story: repeated buybacks cut shares outstanding by 26.3%, so per-share results improved much faster than the company’s total profit pool.

Financial Health Signals

Financial health score not available

Hca Healthcare Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

6/8

Hca Healthcare Inc passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.86x

For every $1 of reported earnings, Hca Healthcare Inc generates $1.86 in operating cash flow ($12.6B OCF vs $6.8B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$75.6B

YoY+7.1%

5Y CAGR+8.0%

Hca Healthcare Inc generated $75.6B in revenue in fiscal year 2025. This represents an increase of 7.1% from the prior year.

Net Income

$6.8B

YoY+17.8%

5Y CAGR+12.6%

10Y CAGR+12.3%

Hca Healthcare Inc reported $6.8B in net income in fiscal year 2025. This represents an increase of 17.8% from the prior year.

EPS (Diluted)

$28.33

YoY+28.8%

5Y CAGR+21.0%

10Y CAGR+19.0%

Hca Healthcare Inc earned $28.33 per diluted share (EPS) in fiscal year 2025. This represents an increase of 28.8% from the prior year.

EBITDA

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

$7.7B

YoY+36.4%

5Y CAGR+3.8%

10Y CAGR+12.5%

Hca Healthcare Inc generated $7.7B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 36.4% from the prior year.

Cash & Debt

$1.0B

YoY-46.2%

5Y CAGR-10.3%

10Y CAGR+3.4%

Hca Healthcare Inc held $1.0B in cash against $41.6B in long-term debt as of fiscal year 2025.

Dividends Per Share

$2.88

YoY+9.1%

5Y CAGR+46.3%

Hca Healthcare Inc paid $2.88 per share in dividends in fiscal year 2025. This represents an increase of 9.1% from the prior year.

Shares Outstanding

224M

YoY-10.0%

5Y CAGR-8.0%

10Y CAGR-5.6%

Hca Healthcare Inc had 224M shares outstanding in fiscal year 2025. This represents a decrease of 10.0% from the prior year.

Margins & Returns

Net Margin

9.0%

YoY+0.8pp

5Y CAGR+1.7pp

Hca Healthcare Inc's net profit margin was 9.0% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.8 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Return on Equity

Not reported for fiscal year 2025.

Capital Allocation

Share Buybacks

$10.1B

YoY+66.6%

5Y CAGR+86.9%

10Y CAGR+15.4%

Hca Healthcare Inc spent $10.1B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 66.6% from the prior year.

Capital Expenditures

$4.9B

YoY+1.4%

5Y CAGR+11.8%

10Y CAGR+7.6%

Hca Healthcare Inc invested $4.9B in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 1.4% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

HCA Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

HCA annual income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$76.4B	$75.6B+7.1%	$70.6B+8.7%	$65.0B+7.9%	$60.2B+2.5%	$58.8B+14.0%	$51.5B+0.4%	$51.3B+10.0%	$46.7B+7.0%	$43.6B+5.1%	$41.5B	N/A	$36.9B+8.0%	$34.2B+3.5%	$33.0B+11.2%	$29.7B
SG&A Expenses	$555.0M	$548.0M+30.2%	$421.0M+19.3%	$353.0M+15.0%	$307.0M-8.9%	$337.0M-19.0%	$416.0M+12.4%	$370.0M+7.6%	$344.0M+1.2%	$340.0M-0.9%	$343.0M+4.9%	$327.0M+14.7%	$285.0M-0.7%	$287.0M+15.7%	$248.0M+8.8%	$228.0M
Interest Expense	$2.3B	$2.2B+9.1%	$2.1B+6.3%	$1.9B+11.3%	$1.7B+11.2%	$1.6B-1.1%	$1.6B-13.2%	$1.8B+3.9%	$1.8B+3.8%	$1.7B-1.0%	$1.7B+2.5%	$1.7B-4.5%	$1.7B-5.7%	$1.8B+2.8%	$1.8B-11.7%	$2.0B
Income Tax	$2.0B	$2.0B+9.9%	$1.9B+15.5%	$1.6B-7.5%	$1.7B-17.3%	$2.1B+102.5%	$1.0B-5.1%	$1.1B+16.2%	$946.0M-42.2%	$1.6B+18.9%	$1.4B+9.3%	$1.3B+13.8%	$1.1B+16.6%	$950.0M+7.0%	$888.0M+23.5%	$719.0M
Net Income	$6.8B	$6.8B+17.8%	$5.8B+9.9%	$5.2B-7.1%	$5.6B-18.9%	$7.0B+85.3%	$3.8B+7.1%	$3.5B-7.4%	$3.8B+70.9%	$2.2B-23.3%	$2.9B+35.7%	$2.1B+13.5%	$1.9B+20.5%	$1.6B-3.1%	$1.6B-34.9%	$2.5B
EPS (Diluted)	—	$28.33+28.8%	$22.00+16.0%	$18.97-0.9%	$19.15-9.5%	$21.16+93.6%	$10.93+8.5%	$10.07-5.5%	$10.66+79.2%	$5.95-18.5%	$7.30+46.3%	$4.99+20.0%	$4.16+23.4%	$3.37-3.4%	$3.49-29.8%	$4.97

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$19.1B-2.1%	$19.5B+1.8%	$19.2B+3.0%	$18.6B+1.6%	$18.3B+0.2%	$18.3B+4.6%	$17.5B0.0%	$17.5B
SG&A Expenses	$133.0M-13.1%	$153.0M+10.1%	$139.0M+6.9%	$130.0M+3.2%	$126.0M+5.0%	$120.0M+8.1%	$111.0M+11.0%	$100.0M
Interest Expense	$584.0M+2.1%	$572.0M+2.0%	$561.0M-1.2%	$568.0M+3.8%	$547.0M+3.6%	$528.0M+2.5%	$515.0M+1.8%	$506.0M
Income Tax	$430.0M-15.5%	$509.0M-1.2%	$515.0M-1.7%	$524.0M+4.4%	$502.0M+12.3%	$447.0M+5.4%	$424.0M-22.9%	$550.0M
Net Income	$1.6B-13.7%	$1.9B+14.3%	$1.6B-0.6%	$1.7B+2.7%	$1.6B+12.0%	$1.4B+13.2%	$1.3B-13.1%	$1.5B
EPS (Diluted)	$7.15	N/A	$6.96+1.9%	$6.83+5.9%	$6.45	N/A	$4.88-11.8%	$5.53

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income.

TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

HCA Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

HCA annual balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$60.7B+2.0%	$59.5B+5.9%	$56.2B+7.2%	$52.4B+3.3%	$50.7B+6.8%	$47.5B+5.4%	$45.1B+14.9%	$39.2B+7.1%	$36.6B+8.4%	$33.8B+3.1%	$32.7B+5.7%	$31.0B+8.3%	$28.6B+1.8%	$28.1B+4.4%	$26.9B
Current Assets	$15.8B-3.8%	$16.4B+10.0%	$14.9B+9.4%	$13.6B+0.7%	$13.5B+9.8%	$12.3B+10.2%	$11.2B+9.6%	$10.2B+2.4%	$10.0B+9.8%	$9.1B-1.6%	$9.2B+3.4%	$8.9B+11.1%	$8.0B+3.5%	$7.8B+7.3%	$7.2B
Cash & Equivalents	$1.0B-46.2%	$1.9B+106.7%	$935.0M+3.0%	$908.0M-37.4%	$1.5B-19.1%	$1.8B+188.7%	$621.0M+23.7%	$502.0M-31.4%	$732.0M+13.3%	$646.0M-12.8%	$741.0M+30.9%	$566.0M+36.7%	$414.0M-41.3%	$705.0M+89.0%	$373.0M
Inventory	$1.7B-4.9%	$1.7B-14.0%	$2.0B-2.3%	$2.1B+4.1%	$2.0B-1.9%	$2.0B+9.5%	$1.8B+6.8%	$1.7B+10.1%	$1.6B+4.7%	$1.5B+4.4%	$1.4B+12.5%	$1.3B+8.5%	$1.2B+8.6%	$1.1B+3.0%	$1.1B
Accounts Receivable	$10.9B+1.1%	$10.8B+8.0%	$10.0B+12.0%	$8.9B+9.8%	$8.1B+14.8%	$7.1B-4.5%	$7.4B+8.7%	$6.8B+4.4%	$6.5B+11.6%	$5.8B-1.1%	$5.9B+3.4%	$5.7B+9.3%	$5.2B+11.5%	$4.7B+3.1%	$4.5B
Total Liabilities	$66.7B+7.6%	$62.0B+6.9%	$58.0B+5.0%	$55.2B+6.8%	$51.7B+10.1%	$46.9B+2.8%	$45.6B+8.3%	$42.1B+1.3%	$41.6B+5.6%	$39.4B+1.5%	$38.8B+3.5%	$37.5B+4.8%	$35.8B-1.8%	$36.4B+7.4%	$33.9B
Current Liabilities	$16.4B+7.7%	$15.2B+19.9%	$12.7B+27.8%	$9.9B+3.3%	$9.6B+10.1%	$8.7B+12.2%	$7.8B+2.5%	$7.6B+22.9%	$6.2B+5.6%	$5.8B+5.8%	$5.5B+0.7%	$5.5B-3.8%	$5.7B-7.7%	$6.2B+11.1%	$5.6B
Long-Term Debt	$41.6B+8.5%	$38.3B+3.1%	$37.2B-1.4%	$37.7B+9.8%	$34.3B+11.5%	$30.8B-8.3%	$33.6B+4.8%	$32.0B-2.5%	$32.9B+5.4%	$31.2B+3.0%	$30.3B+4.0%	$29.1B+5.4%	$27.6B+0.3%	$27.5B+7.2%	$25.6B
Total Equity	-$6.0B-141.2%	-$2.5B-40.9%	-$1.8B+35.9%	-$2.8B-196.6%	-$933.0M-263.1%	$572.0M+120.4%	-$2.8B+43.3%	-$5.0B+27.3%	-$6.8B+6.8%	-$7.3B+3.9%	-$7.6B+3.7%	-$7.9B+4.5%	-$8.3B+14.4%	-$9.7B-17.0%	-$8.3B
Retained Earnings	-$5.7B-170.6%	-$2.1B-56.4%	-$1.4B+40.7%	-$2.3B-328.6%	-$532.0M-168.5%	$777.0M+133.0%	-$2.4B+48.6%	-$4.6B+30.0%	-$6.5B+6.3%	-$7.0B+5.0%	-$7.3B+3.1%	-$7.6B+19.4%	-$9.4B+14.2%	-$11.0B-16.3%	-$9.4B

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$61.5B+1.2%	$60.7B+1.6%	$59.7B+0.4%	$59.5B-0.4%	$59.8B+0.5%	$59.5B+0.1%	$59.5B+3.6%	$57.4B
Current Assets	$16.1B+1.7%	$15.8B+3.3%	$15.3B-1.8%	$15.6B-4.3%	$16.3B-1.0%	$16.4B-1.5%	$16.7B+9.8%	$15.2B
Cash & Equivalents	$940.0M-9.6%	$1.0B+4.3%	$997.0M+6.2%	$939.0M-11.4%	$1.1B-45.2%	$1.9B-33.1%	$2.9B+247.5%	$831.0M
Inventory	$1.7B+1.8%	$1.7B-4.7%	$1.7B-3.2%	$1.8B-0.1%	$1.8B+3.2%	$1.7B-2.1%	$1.8B-1.3%	$1.8B
Accounts Receivable	$11.3B+4.2%	$10.9B+4.2%	$10.4B-0.3%	$10.5B-5.7%	$11.1B+3.1%	$10.8B+8.4%	$9.9B-3.2%	$10.2B
Total Liabilities	$67.8B+1.5%	$66.7B+2.6%	$65.1B+1.8%	$63.9B+1.0%	$63.3B+2.1%	$62.0B+0.6%	$61.6B+4.5%	$59.0B
Current Liabilities	$19.3B+17.8%	$16.4B-8.6%	$17.9B+12.3%	$15.9B+16.9%	$13.6B-10.2%	$15.2B+1.9%	$14.9B+4.2%	$14.3B
Long-Term Debt	$39.5B-5.1%	$41.6B+8.3%	$38.4B-2.5%	$39.4B-4.1%	$41.1B+7.1%	$38.3B+0.1%	$38.3B+5.4%	$36.3B
Total Equity	-$6.3B-4.6%	-$6.0B-13.0%	-$5.3B-21.4%	-$4.4B-24.9%	-$3.5B-40.8%	-$2.5B-14.5%	-$2.2B-36.4%	-$1.6B
Retained Earnings	-$6.0B-4.4%	-$5.7B-14.0%	-$5.0B-22.8%	-$4.1B-29.2%	-$3.2B-49.6%	-$2.1B-17.0%	-$1.8B-54.4%	-$1.2B

Not reported in any period shown, so not listed: Goodwill.

HCA Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

HCA annual cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$13.0B	$12.6B+20.2%	$10.5B+11.5%	$9.4B+10.7%	$8.5B-4.9%	$9.0B-3.0%	$9.2B+21.4%	$7.6B+12.4%	$6.8B+24.6%	$5.4B-4.0%	$5.7B+19.4%	$4.7B+6.4%	$4.4B+20.9%	$3.7B-11.9%	$4.2B+6.2%	$3.9B
Capital Expenditures	$5.1B	$4.9B+1.4%	$4.9B+2.8%	$4.7B+7.9%	$4.4B+22.9%	$3.6B+26.2%	$2.8B-31.8%	$4.2B+16.4%	$3.6B+18.5%	$3.0B+9.2%	$2.8B+16.2%	$2.4B+9.1%	$2.2B+12.0%	$1.9B+4.4%	$1.9B+10.9%	$1.7B
Free Cash Flow	$7.9B	$7.7B+36.4%	$5.6B+20.3%	$4.7B+13.6%	$4.1B-23.3%	$5.4B-15.9%	$6.4B+85.7%	$3.4B+8.0%	$3.2B+32.2%	$2.4B-16.7%	$2.9B+22.6%	$2.4B+3.8%	$2.3B+30.8%	$1.7B-24.9%	$2.3B+2.6%	$2.3B
Investing Cash Flow	-$5.2B	-$5.0B-1.1%	-$4.9B+7.2%	-$5.3B-56.9%	-$3.4B-28.2%	-$2.6B+22.1%	-$3.4B+40.7%	-$5.7B-46.6%	-$3.9B+8.8%	-$4.3B-32.1%	-$3.2B	N/A	-$2.9B-24.4%	-$2.3B-13.7%	-$2.1B+31.1%	-$3.0B
Financing Cash Flow	-$7.9B	-$8.6B-86.6%	-$4.6B-11.9%	-$4.1B+27.6%	-$5.7B+15.0%	-$6.7B-42.3%	-$4.7B-164.1%	-$1.8B+42.4%	-$3.1B-189.8%	-$1.1B+57.7%	-$2.5B	N/A	-$1.4B+15.2%	-$1.6B+8.7%	-$1.8B-82.4%	-$976.0M
Dividends Paid	$682.0M	$679.0M-1.6%	$690.0M+4.4%	$661.0M+1.2%	$653.0M+4.6%	$624.0M+307.8%	$153.0M-72.2%	$550.0M+12.9%	$487.0M	$0	N/A	N/A	$7.0M-56.3%	$16.0M-99.5%	$3.1B+10054.8%	$31.0M
Share Buybacks	$9.1B	$10.1B+66.6%	$6.0B+58.5%	$3.8B-45.6%	$7.0B-14.8%	$8.2B+1762.8%	$441.0M-57.2%	$1.0B-32.6%	$1.5B-25.4%	$2.1B-25.4%	$2.8B+14.8%	$2.4B+37.0%	$1.8B+250.0%	$500.0M	N/A	$1.5B

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$2.0B-14.6%	$2.4B-46.6%	$4.4B+4.9%	$4.2B+155.0%	$1.7B-35.5%	$2.6B-27.2%	$3.5B+78.3%	$2.0B
Capital Expenditures	$1.1B-24.8%	$1.5B+15.6%	$1.3B+9.5%	$1.2B+18.7%	$991.0M-22.9%	$1.3B+7.9%	$1.2B-7.0%	$1.3B
Free Cash Flow	$895.0M+2.9%	$870.0M-72.2%	$3.1B+3.1%	$3.0B+359.7%	$660.0M-48.2%	$1.3B-45.2%	$2.3B+236.8%	$690.0M
Investing Cash Flow	-$1.3B+2.7%	-$1.3B+5.1%	-$1.4B-11.0%	-$1.3B-21.2%	-$1.0B+23.3%	-$1.3B+0.4%	-$1.4B-1.5%	-$1.3B
Financing Cash Flow	-$830.0M+16.9%	-$999.0M+66.3%	-$3.0B+3.9%	-$3.1B-106.6%	-$1.5B+30.9%	-$2.2B-1866.4%	-$110.0M+89.9%	-$1.1B
Dividends Paid	$183.0M+13.0%	$162.0M-2.4%	$166.0M-2.9%	$171.0M-5.0%	$180.0M+9.1%	$165.0M-2.4%	$169.0M-1.2%	$171.0M
Share Buybacks	$1.6B-38.6%	$2.6B+2.4%	$2.5B-0.3%	$2.5B0.0%	$2.5B+47.4%	$1.7B-5.3%	$1.8B+31.3%	$1.4B

HCA Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

HCA annual financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Net Margin	9.0%+0.8pp	8.2%+0.1pp	8.1%-1.3pp	9.4%-2.5pp	11.8%+4.6pp	7.3%+0.5pp	6.8%-1.3pp	8.1%+3.0pp	5.1%-1.9pp	7.0%	N/A	5.1%+0.5pp	4.5%-0.3pp	4.9%-3.4pp	8.3%
Return on Equity	N/A	N/A	N/A	N/A	N/A	656.3%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	11.2%+1.5pp	9.7%+0.4pp	9.3%-1.4pp	10.8%-2.9pp	13.7%+5.8pp	7.9%+0.1pp	7.8%-1.9pp	9.7%+3.6pp	6.1%-2.5pp	8.6%+2.1pp	6.5%+0.5pp	6.0%+0.6pp	5.4%-0.3pp	5.7%-3.4pp	9.2%
Current Ratio	0.97-0.1x	1.08-0.1x	1.18-0.2x	1.380.0x	1.410.0x	1.420.0x	1.44+0.1x	1.35-0.3x	1.62+0.1x	1.56-0.1x	1.670.0x	1.63+0.2x	1.41+0.2x	1.260.0x	1.30
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	53.84	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCF Margin	10.2%+2.2pp	8.0%+0.8pp	7.2%+0.4pp	6.9%-2.3pp	9.2%-3.3pp	12.4%+5.7pp	6.7%-0.1pp	6.8%+1.3pp	5.5%-1.4pp	7.0%	N/A	6.2%+1.1pp	5.1%-1.9pp	7.0%-0.6pp	7.6%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Net Margin	8.5%-1.1pp	9.6%+1.0pp	8.6%-0.3pp	8.9%+0.1pp	8.8%+0.9pp	7.9%+0.6pp	7.3%-1.1pp	8.3%
Return on Assets	2.6%-0.5pp	3.1%+0.3pp	2.8%0.0pp	2.8%+0.1pp	2.7%+0.3pp	2.4%+0.3pp	2.1%-0.4pp	2.5%
Current Ratio	0.83-0.1x	0.97+0.1x	0.85-0.1x	0.98-0.2x	1.19+0.1x	1.080.0x	1.12+0.1x	1.06
FCF Margin	4.7%+0.2pp	4.5%-11.9pp	16.3%0.0pp	16.3%+12.7pp	3.6%-3.4pp	7.0%-6.3pp	13.3%+9.3pp	3.9%

Not reported in any period shown, so not listed: Gross Margin, Operating Margin.

Note: Shareholder equity is negative (-$6.0B), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.97), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Tenet Healthcare Corp THC

$21.5B

Univ Health Svc UHS

$10.2B

Fresenius Med Cr FMS

$12.6B

Encompass Health Corp EHC

$12.3B

Ensign Group Inc ENSG

$10.6B

Where Hca Healthcare Inc Ranks

Frequently Asked Questions

What is Hca Healthcare Inc's annual revenue?

Hca Healthcare Inc (HCA) reported $75.6B in total revenue for fiscal year 2025. This represents a 7.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Hca Healthcare Inc's revenue growing?

Hca Healthcare Inc (HCA) revenue grew by 7.1% year-over-year, from $70.6B to $75.6B in fiscal year 2025.

Is Hca Healthcare Inc profitable?

Yes, Hca Healthcare Inc (HCA) reported a net income of $6.8B in fiscal year 2025, with a net profit margin of 9.0%.

How much debt does Hca Healthcare Inc have?

As of fiscal year 2025, Hca Healthcare Inc (HCA) had $1.0B in cash and equivalents against $41.6B in long-term debt.

What is Hca Healthcare Inc's net profit margin?

Hca Healthcare Inc (HCA) had a net profit margin of 9.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Hca Healthcare Inc pay dividends?

Yes, Hca Healthcare Inc (HCA) paid $2.88 per share in dividends during fiscal year 2025.

What is Hca Healthcare Inc's free cash flow?

Hca Healthcare Inc (HCA) generated $7.7B in free cash flow during fiscal year 2025. This represents a 36.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Hca Healthcare Inc's operating cash flow?

Hca Healthcare Inc (HCA) generated $12.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Hca Healthcare Inc's total assets?

Hca Healthcare Inc (HCA) had $60.7B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Hca Healthcare Inc's capital expenditures?

Hca Healthcare Inc (HCA) invested $4.9B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Hca Healthcare Inc buy back shares?

Yes, Hca Healthcare Inc (HCA) spent $10.1B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Hca Healthcare Inc have outstanding?

Hca Healthcare Inc (HCA) had 224M shares outstanding as of fiscal year 2025.

What is Hca Healthcare Inc's current ratio?

Hca Healthcare Inc (HCA) had a current ratio of 0.97 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Hca Healthcare Inc's return on assets (ROA)?

Hca Healthcare Inc (HCA) had a return on assets of 11.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Why is Hca Healthcare Inc's debt-to-equity ratio negative or not reported?

Hca Healthcare Inc (HCA) has negative shareholder equity of -$6.0B as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Hca Healthcare Inc's Piotroski F-Score?

Hca Healthcare Inc (HCA) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Hca Healthcare Inc's earnings high quality?

Hca Healthcare Inc (HCA) has an earnings quality ratio of 1.86x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.